Justin Lampropoulos began his career in healthcare more than a decade ago as a member of Merit’s commercial organization and subsequently held positions of increasing responsibility. Lampropoulos currently serves as the President of EMEA. He has held previous European commercial appointments notably, residing in Europe from 2010 to 2015.
Prior to his appointment, he served as the Executive Vice President of Sales, Marketing, and Strategy for U.S., Europe, and Global Marketing. During this appointment, Lampropoulos led the creation and implementation of Merit’s specialized franchises: Merit Vascular, Merit Oncology (formerly Cianna Medical), and Merit Spine.
Throughout his healthcare career, Lampropoulos has led the creation of multiple global commercial operating models and held senior commercial leadership positions in a variety of geographies and functions. These include commercial leadership roles in global marketing, product management, Merit OEM, U.S., Western Europe, and emerging markets. Additionally, he has established and led several international organizations and commercial operating models, including Merit’s commercial footprint in the Middle East, Russia, Africa, and a number of countries within the European Union.
Lampropoulos has been named a 40 Under 40 Generation Next Medtech Innovator by Medical Device and Diagnostic Industry—a national publication in the U.S.—and Sales and Marketer of the Year by Utah Business Magazine.